10x Genomics Inc (TXG)
14.43
-0.49
(-3.28%)
USD |
NASDAQ |
Nov 14, 12:36
10x Genomics Max Drawdown (5Y): 92.66% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.66% |
| September 30, 2024 | 92.24% |
| August 31, 2024 | 92.24% |
| July 31, 2024 | 92.24% |
| June 30, 2024 | 90.39% |
| May 31, 2024 | 89.07% |
| April 30, 2024 | 87.94% |
| March 31, 2024 | 87.94% |
| February 29, 2024 | 87.94% |
| January 31, 2024 | 87.94% |
| December 31, 2023 | 87.94% |
| November 30, 2023 | 87.94% |
| October 31, 2023 | 87.94% |
| September 30, 2023 | 87.94% |
| August 31, 2023 | 87.94% |
| July 31, 2023 | 87.94% |
| June 30, 2023 | 87.94% |
| May 31, 2023 | 87.94% |
| April 30, 2023 | 87.94% |
| March 31, 2023 | 87.94% |
| February 28, 2023 | 87.94% |
| January 31, 2023 | 87.94% |
| December 31, 2022 | 87.94% |
| November 30, 2022 | 87.94% |
| October 31, 2022 | 87.94% |
| Date | Value |
|---|---|
| September 30, 2022 | 85.93% |
| August 31, 2022 | 83.74% |
| July 31, 2022 | 82.88% |
| June 30, 2022 | 81.74% |
| May 31, 2022 | 80.41% |
| April 30, 2022 | 76.40% |
| March 31, 2022 | 72.48% |
| February 28, 2022 | 65.25% |
| January 31, 2022 | 57.57% |
| December 31, 2021 | 51.63% |
| November 30, 2021 | 51.63% |
| October 31, 2021 | 51.63% |
| September 30, 2021 | 51.63% |
| August 31, 2021 | 51.63% |
| July 31, 2021 | 51.63% |
| June 30, 2021 | 51.63% |
| May 31, 2021 | 51.63% |
| April 30, 2021 | 51.63% |
| March 31, 2021 | 51.63% |
| February 28, 2021 | 51.63% |
| January 31, 2021 | 51.63% |
| December 31, 2020 | 51.63% |
| November 30, 2020 | 51.63% |
| October 31, 2020 | 51.63% |
| September 30, 2020 | 51.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
25.69%
Minimum
Nov 2019
92.66%
Maximum
Oct 2024
69.18%
Average
78.40%
Median
Max Drawdown (5Y) Benchmarks
| Omnicell Inc | 86.05% |
| American Shared Hospital Services | 73.16% |
| Astrana Health Inc | 77.25% |
| Cryo-Cell International Inc | 76.33% |
| P3 Health Partners Inc | -- |